Clinical Trial Update: A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating VX-407 for safety, tolerability, and pharmacokinetics in healthy participants has completed, with Autosomal Dominant Polycys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• VX-407

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 1 | Status: COMPLETED